Synthesis, biological evaluation, and structure–activity relationships of tri- and tetrasubstituted olefins related to isocombretastatin A-4 as new tubulin inhibitors
- 19 September 2012
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 11 (3) , 430-442
Abstract
The synthesis and structure–activity relationships associated with a series of 1,1-diarylethylene tubulin polymerization inhibitors 3 and 4 are described. The key step for their preparation involves a palladium-catalyzed coupling of N-arylsulfonylhydrazones with aryl halides, thus providing flexible and convergent access to tri- and tetrasubstituted 1,1-diarylolefins 3 and 4 related to isocombretastatin A-4 (isoCA-4). These compounds have been evaluated for tubulin polymerization inhibitory activity as well as for cytotoxic activity. The most potent compounds are 1,1-diaryl-2-methoxyethylenes 4b, 4d and 4e having a trisubstituted double bond. They exhibited good antiproliferative activity against various human cancer cell lines (GI50 = 8–80 nM). Compounds 4b and 4e strongly inhibited tubulin polymerization with IC50 values of 2 and 3 μM, respectively, and induced cell cycle arrest in the G2/M phase in the K562 cell line. Docking studies in the colchicine binding site of tubulin allowed identification of residues most likely to interact with these inhibitors and explain their potent anti-tubulin activity.Keywords
This publication has 59 references indexed in Scilit:
- Conformationnally restricted naphthalene derivatives type isocombretastatin A-4 and isoerianin analogues: Synthesis, cytotoxicity and antitubulin activityEuropean Journal of Medicinal Chemistry, 2012
- Collateral sensitivity as a strategy against cancer multidrug resistanceDrug Resistance Updates, 2012
- N-Tosylhydrazones: versatile reagents for metal-catalyzed and metal-free cross-coupling reactionsChemical Society Reviews, 2011
- A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancerBritish Journal of Cancer, 2010
- Synthesis, Biological Evaluation of 1,1‐Diarylethylenes as a Novel Class of Antimitotic AgentsChemMedChem, 2009
- Palladium-Catalyzed Markovnikov Terminal Arylalkynes Hydrostannation: Application to the Synthesis of 1,1-DiarylethylenesThe Journal of Organic Chemistry, 2008
- In Vitro Metabolism Study of Combretastatin A-4 in Rat and Human Liver MicrosomesDrug Metabolism and Disposition, 2007
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997
- Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray StructuresJournal of Chemical Information and Computer Sciences, 1994